Barriers for cancer clinical trial enrollment: A qualitative study of the perspectives of healthcare providers
Author:
Funder
University of Nebraska Medical Center
Fred and Pamela Buffett Cancer Center
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference51 articles.
1. Systematic review and meta-analysis of the magnitude of structural, clinical, and physician and patient barriers to cancer clinical trial participation;Unger;JNCI: J. Natl. Cancer Inst.,2019
2. Enrollment and racial disparities in cancer treatment clinical trials in North Carolina;Zullig;N. C. Med. J.,2016
3. Barriers to clinical trial enrollment in racial and ethnic minority patients with cancer;Hamel;Cancer Control,2016
4. Strategies for recruitment and retention of participants in clinical trials;Probstfield;JAMA,2011
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Disparities in Lung Cancer Clinical Trial Discussion and Enrollment at a Safety Net Hospital;Community Health Equity Research & Policy;2023-12-12
2. Advantages of the Combinatorial Molecular Targeted Therapy of Head and Neck Cancer—A Step before Anakoinosis-Based Personalized Treatment;Cancers;2023-08-24
3. Geographic Inequities in Access to Phase 3 Clinical Trials for Inflammatory Bowel Disease in the United States;Clinical Gastroenterology and Hepatology;2023-08
4. Operational Metrics for the ELAINE 2 Study Combining a Traditional Approach With a Just-in-TIME Model;JCO Clinical Cancer Informatics;2023-06
5. The RIC Recruitment & Retention Materials Toolkit – a resource for developing community-informed study materials;Journal of Clinical and Translational Science;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3